Masahiro Suda

451 total citations
22 papers, 379 citations indexed

About

Masahiro Suda is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Masahiro Suda has authored 22 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Hematology. Recurrent topics in Masahiro Suda's work include Respiratory and Cough-Related Research (4 papers), Histiocytic Disorders and Treatments (4 papers) and Parvovirus B19 Infection Studies (4 papers). Masahiro Suda is often cited by papers focused on Respiratory and Cough-Related Research (4 papers), Histiocytic Disorders and Treatments (4 papers) and Parvovirus B19 Infection Studies (4 papers). Masahiro Suda collaborates with scholars based in Japan, United Kingdom and France. Masahiro Suda's co-authors include Kohji Ueda, Akinobu Matsuzaki, Shouichi Ohga, Mari Nishizaki, Toshiro Yadomae, Naohito Ohno, Yoshiyuki Adachi, Takeshi Inamitsu, Junji Irie and Hiroshi Nagura and has published in prestigious journals such as Blood, British Journal of Haematology and Carbohydrate Research.

In The Last Decade

Masahiro Suda

22 papers receiving 368 citations

Peers

Countries citing papers authored by Masahiro Suda

Since Specialization

Citations

This map shows the geographic impact of Masahiro Suda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Suda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Suda more than expected).

Fields of papers citing papers by Masahiro Suda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Suda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Suda. The network helps show where Masahiro Suda may publish in the future.

Co-authorship network of co-authors of Masahiro Suda

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Suda. A scholar is included among the top collaborators of Masahiro Suda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Suda. Masahiro Suda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of inhaled KP-496, a novel dual antagonist of the cysteinyl leukotriene and thromboxane A2 receptors, on a bleomycin-induced pulmonary fibrosis model in mice 2010 ·Pulmonary Pharmacology & Therapeutics ·(unknown), Masahiro Suda, (unknown), (unknown), (unknown), (unknown), Ryota Saito, T. Nakamura	8
2	The Effects of Inhaled KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor and Thromboxane A<sub>2</sub> Receptor, on Allergic Asthmatic Responses in Guinea Pigs 2009 ·Pharmacology ·Masahiro Suda, (unknown), (unknown), (unknown), (unknown), T. Nakamura, Yoshimasa Takahashi, Hiroyuki Tanaka, Hiroichi Nagai	4
3	Effects of KP-496, a Novel Dual Antagonist for Leukotriene D4 and Thromboxane A2 Receptors, on Contractions Induced by Various Agonists in the Guinea Pig Trachea 2006 ·Allergology International ·(unknown), (unknown), Masahiro Suda, Takashi Maeda, Yoshiyuki Hiyama	8
4	Dominant β-Thalassemia with Hemoglobin Hradec Kralove: Enhanced Hemolysis in the Spleen 2003 ·International Journal of Hematology ·Shouichi Ohga, Akihiko Nomura, Hidetoshi Takada, Junko Kato, Hiroshi Ideguchi, Yukio Hattori, Masahiro Suda, Sachiyo Suita, Toshiro Hara	4
5	Structural and functional abnormalities in the spleen of an mFtz-F1 gene-disrupted mouse. 1999 ·Blood ·(unknown), (unknown), (unknown), Masahiro Suda, Manabu Nakashima, Hironobu Sasano, Yoshiaki Hataba, Chun Li, Junichi Fukata, Junji Irie, Takeshi Watanabe, Hiroshi Nagura, En Li	76
6	Synthesis and antibacterial activity of novel 7-(3-substituted-3 or 4-trifluoromethyl-1-pyrrolidinyl)-8-methoxyfluoroquinolones 1998 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Jun Nakano, (unknown), Hisato Senda, (unknown), Yoshiyuki Tatsumi, Masahiro Suda, (unknown)	26
7	Granulocyte transfusion: Stimulation of low dose granulocyte colony‐stimulating factor in donors for leukapheresis 1996 ·Pediatrics International ·Akihiko Nomura, Shouichi Ohga, Akinobu Matsuzaki, (unknown), Shoichi Inaba, Masahiro Suda, Kohji Ueda	3
8	Kupffer cells play important roles in the metabolic degradation of a soluble anti-tumor (1 â 3)-Î²-d-glucan, SSG, in mice 1996 ·FEMS Immunology & Medical Microbiology ·Masahiro Suda, Naohito Ohno, (unknown), (unknown), Yoshiyuki Adachi, Toshiro Yadomae	23
9	Chronic myelomonocytic leukaemia with t(8;9)(p11;q34) in childhood: an example of the 8p11 myeloproliferative disorder? 1996 ·British Journal of Haematology ·Hideki Nakayama, Takeshi Inamitsu, (unknown), (unknown), Masahiro Suda, Akinobu Matsuzaki, Kohji Ueda	29
10	Gel-to-sol transition of 13C-labeled (1 → 3)-β-d-glucan, 13C-SSG, assessed by 13C nuclear magnetic resonance (13C-NMR) spectroscopy 1995 ·Carbohydrate Research ·Masahiro Suda, Naohito Ohno, (unknown), Toshiro Yadomae	5
11	Metabolic¹³C-Labeling of An Antitumor (1→3)-β-D-Glucan, SSG, fromSclerotinia sclerotiorumIFO 9395 1995 ·Bioscience Biotechnology and Biochemistry ·Masahiro Suda, Naohito Ohno, (unknown), Toshiro Yadomae	5
12	Preparation and properties of metabolically 3H- or 13C-labeled (1 → 3)-β-d-glucan, SSG, from Sclerotinia sclerotiorum IFO 9395 1994 ·Carbohydrate Research ·Masahiro Suda, Naohito Ohno, Yoshiyuki Adachi, Toshiro Yadomae	6
13	Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis 1994 ·British Journal of Haematology ·Akinobu Matsuzaki, Takeshi Inamitsu, Toshiaki Watanabe, Shouichi Ohga, Eiichi Ishii, (unknown), Hideko Tasaka, Masahiro Suda, Kohji Ueda	22
14	Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity. 1993 ·PubMed ·Shouichi Ohga, Akinobu Matsuzaki, Mari Nishizaki, (unknown), (unknown), Masahiro Suda, Kohji Ueda	108
15	Tissue Distribution of Intraperitoneally Administered (1.RAR.3)-.BETA.-D-Glucan (SSG), a Highly Branched Antitumor Glucan, in Mice. 1992 ·Journal of Pharmacobio-Dynamics ·Masahiro Suda, Naohito Ohno, Yoshiyuki Adachi, Toshiro Yadomae	15
16	Malignant Histiocytosis Involving Pancreas at Initial Presentation 1989 ·Pediatric Hematology and Oncology ·Toshiro Hara, Hisaji Igarashi, Yumi Mizuno, Kohji Ueda, Masahiro Suda, (unknown)	1
17	Histiocytic Hemophagocytosis in the Bone Marrow in Children with Sepsis and Disseminated Intravascular Coagulation 1989 ·Pediatrics International ·Toshiro Hara, Satoshi Honjo, Chiaki Miyazaki, Yumi Mizuno, Masahiro Suda, (unknown), Kohji Ueda	4
18	Eosinophilia in Children 1987 ·Journal of Pediatric Hematology/Oncology ·Eiichi Ishii, Yumi Mizuno, Toshiro Hara, Jun Okamura, (unknown), (unknown), Masahiro Suda, Morishige Takeshita, Masahiro Kikuchi, Kohji Ueda	2
19	Malignant histiocytosis in infants: Surface marker analysis of malignant cells in two cases 1987 ·Medical and Pediatric Oncology ·Eiichi Ishii, Toshiro Hara, Jun Okamura, Masahiro Suda, (unknown), (unknown), Kohji Ueda	6
20	Familial erythrophagocytic lymphohistiocytosis: Surface marker analysis using monoclonal antibodies 1987 ·European Journal Of Haematology ·Eiichi Ishii, Toshiro Hara, Shouichi Ohga, Kohji Ueda, Masahiro Suda, Junji Nakamura, (unknown), Yoshiro Tsuji	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact